0001104659-24-043246.txt : 20240403
0001104659-24-043246.hdr.sgml : 20240403
20240403200013
ACCESSION NUMBER: 0001104659-24-043246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwendenman Andrew
CENTRAL INDEX KEY: 0001977879
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 24821067
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 500 UNICORN PARK DRIVE
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm2410652-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-01
0
0001737953
Replimune Group, Inc.
REPL
0001977879
Schwendenman Andrew
C/O REPLIMUNE GROUP, INC.
500 UNICORN PARK DRIVE, SUITE 303
WOBURN
MA
01801
0
1
0
0
Chief Accounting Officer
0
Common Stock
2024-04-01
4
A
0
17775
0
A
40536
D
Employee Stock Option (right to buy)
7.73
2024-04-01
4
A
0
53325
0
A
2034-04-01
Common Stock
53325
53325
D
Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2025 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2028, subject to the Reporting Person's continuous service to the Issuer.
25% of the shares underlying this stock option vest on April 1, 2025, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
/s/ Shawn Glidden, attorney-in-fact
2024-04-03